Mizuho Medy Co.,Ltd.

4595.T
Drug Manufacturers - Specialty & Generic
2026/08/12 Updated
Market Cap: $204.2M (¥32.5B)
Stock Price: $10.72 (¥1,707)
Exchange Rate: 1 USD = ¥159.24

Financial Summary

Presenting the results for the 2Q26 and full-year guidance, along with future growth strategies. Disclosure of revenue and profit trends, segment-by-segment status, outlook, and risk factors.

Importance:
Page Updated: August 12, 2026
IR Disclosure Date: August 12, 2026

Key Figures

  • Sales: Unknown
  • Operating income: Unknown
  • Ordinary income: Unknown

AI要約

Section Title

I. Overview of the company and business segments; II. Trend and drivers of performance; III. Presentation of 2Q26 results and full-year guidance; IV. Outlook for future growth strategy and risk factors, and market environment.

Section 2 Heading

Description of revenue trends, profit structure, and contribution by segment with accompanying charts. Demand trends for COVID-19 related tests and POCT devices, planned new product releases, and mid-to-long-term strategy for 2023–2025.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

Meizhu Medical Co., Ltd.

Company overview · Stock price · Financial data · All IR

View company page →